Soft Tissue InfectionsPhase 4NCT02097615
Diabetic Foot Ulcer. Effectiveness of Chlorhexidine Gluconate 0.125 % Compared With Sterile Deionized Water
A Phase 4 study testing chlorhexidine gluconate and deionized water in people with Soft Tissue Infections, run by Universidad de Guanajuato at 1 site in Mexico.
Trial summary
At present research has generated controversy regarding the utility of antiseptics in wound management for diabetic foot ulcers syndrome. However, these studies have been done in tissues and animal models. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Soft Tissue Infections
- What is being tested?
- chlorhexidine gluconate and deionized water
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 24 participants
- Where
- 1 siteMexico
- Study dates
- May 2014to Dec 2014
- Phase
- Phase 4
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Indistinct gender
- Patients over 18 years with Diabetes Mellitus and
- Submit ulcer from diabetic foot syndrome not involving tendon , capsule or bone.
- With proper state of vascular perfusion.
Who cannot join
- Ulcers in patients with interdigital or difficult to measure the affected surface areas.
- Patients not be located at follow-up or wish to stop participating in the study.
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Clinical Trial of the Effectiveness of Chlorhexidine Gluconate 0.125 % Compared With Sterile Deionized Water in the Closure of Diabetic Foot Ulcer Syndrome.
At present research has generated controversy regarding the utility of antiseptics in wound management for diabetic foot ulcers syndrome. However, these studies have been done in tissues and animal models. This study involves the best presently antiseptic for residual effect and low toxicity in an approach to eliminate microorganisms promoters formation of biofilm, contributing to the treatment for accelerated closure the diabetic foot ulcers syndrome .
So it is necessary to determine if irrigation ulcer diabetic foot syndrome with chlorhexidine 0.125 % aqueous solution determines the decrease of the surface to a greater extent than the standard treatment using irrigation with sterile deionized water .
Read the detailed description
The present study be made performed at the Hospital General Leon.
Population:
People with Diabetes Mellitus state of Guanajuato.
Universe:
People with diabetes mellitus and diabetic foot syndrome Guanajuato state . sample: Will be evaluated in patients with diabetes mellitus presenting loss of continuity of the skin of the lower limbs and coming to the clinic wound´s of the León General Hospital . This clinic provides services to patients in the state of Guanajuato with diabetic foot syndrome, including them within a multidisciplinary management program .
Calculation of Sample :
72 patients; more eight for lost estimates, 40 patients for each group are required to have a 80 % chance of detecting , with a significance level of 5%, an increase in the primary outcome measure of 5% in the control group and 6 % in group experimental .
Alpha: 5 % Power : 80 %
Inclusion Criteria:
Indistinct gender Patients over 18 years with Diabetes Mellitus and submit ulcer from diabetic foot syndrome not involving tendon , capsule or bone.
With proper state of vascular perfusion.
Exclusion Criteria :
Ulcers in patients with interdigital or difficult to measure the affected surface areas.
Patients not be located at follow-up or wish to stop participating in the study.
Methodology:
Will be invited to participate in the study patients with diabetes mellitus consecutive presented with ulcers plantar to IA or IB grade classification system ulcers , University of Texas, in the area of Clinical wound´s of the Hospital General Leon between Abril and November 2014.
After explaining the study information and check which is understandable , they provide the sheet to be signed informed consent.
Subsequently selected patients will be given a vascular ultrasound to measure the ankle brachial index and determine the absence of vascular compromise.
They carry out their medical history with emphasis on analyzing clinical data , including the characteristics of the ulcer (type of exudate , measured surface area affected , type of tissue involved in the ulcer to its depth ) and biochemical parameters .
Be weighed and measured at the first visit and not having biochemical data are requested to collect this information in subsequent follow-up visit .
They were then treated with the principles of the standard treatment, under the following criteria :
- Remove the ulcer exudate by spraying one of the two ingredients making mechanical drive for 5 minutes, or until completely negative to the visual evidence of exudate.
- Completely remove hyperkeratosis and devitalized tissue from the periphery of the ulcer with cutting material dissection with sterile dressing and drag , until visually eliminate the exudate.
- The treated area is dry and sore
- Two photographs at a distance of 20 cm perpendicular to the ulcer will be taken, covering a 1 square centimeter reference for measuring the area affected by diabetic foot ulcer syndrome.
- The solution so blinded to the ulcer and covered with sterile dressing will be applied for 24 hours .
- The patient will be instructed to continue treatment every 24 hours as follows :
- Sterile dressing will be removed and continuously irrigate for 5 seconds with the ingredient that was assigned .
- Undiscovered for 24 hours , until the next day irrigation dressing area will be placed . Also need to avoid contact with any surface over the affected area until the next assessment .
- Perform the same strategy for 24 hours , and on day 7 will go to the wound clinic to clinical evaluation.
- Every 7 days until complete 6 views, clinical evaluation are performed, irrigation with the selected ingredient and it will take 2 pictures at a distance of 20 cm perpendicular to the boil again , covering a reference of 1 square centimeter to measure the area affected by the diabetic foot ulcer syndrome.
- Every 7 days of initiation of therapy in the clinic consultation wounds measured and circulation and comment the following:
- Ulcer area in square millimeters .
- Coloring of the ulcer .
- Type of exudate ; turbid serous .
- Type of tissue involved in the ulcer to its depth. If any patients have increased intensity of the signs and symptoms of diabetic foot syndrome, classified as a major step on the scale of ulcers Classification System of the University of Texas, perform analysis and comprehensive treatment will be redefined according to the suggestions of ulcer classification system of the University of Texas.
Material cleaning the ulcer :
Ingredient 1: Preparation of spray application of chlorhexidine gluconate 0.125% .
Ingredient 2: Preparation of spray application of sterile deionized water .
Method of application of ingredients as described previously .
Method of randomization : is effected by assigning random numbers balanced computer, the code will be assigned to each of the ingredients which have identical presentations , they will balance to the sample size . The code will not be known by the patient, observer and analyst. Only be known by one of the advisors.
Statistical methods :
The description of the data, in the case of non-numerical variables will be performed by reporting proportions and confidence interval of 95 % (95 %) in the case of numerical variables, the description will be made based on averages and standard deviation or medians and Q1- Q3 range , depending on the result of the Kolmogorov-Smirnov test to evaluate the Gaussian distribution of the data.
Comparison of numerical variables were not performed by Chi square test . Comparison of the rates of reduction in the size of ulcers of diabetic foot syndrome for both treatments will be based on the t test for independent samples or by Kruskal- Wallis test , depending on data distribution .
In all cases be considered as the significance level alpha value <0.05 .
- Conditions
- Soft Tissue Infections
- Being tested
- chlorhexidine gluconate, deionized water
- Keywords
- soft, tissue, infections
- Medical subject headings
- Soft Tissue Infections, Infections
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
chlorhexidine gluconateProcedure or surgery
chlorhexidine gluconate spray of 0.125% . Application in the area of the ulcer every 24 hours for six weeks
deionized waterOther
application every 24 hours six weeks
| Study group | Role | What they receive |
|---|---|---|
| chlorhexidine gluconate | Experimental | application every 24 hours, six weeks Receives: Procedure: chlorhexidine gluconate |
| Other: deionized water | Other | application every 24 hours, six weeks Receives: Other: deionized water |
What is being measured
The primary outcome is the main question the study is designed to answer.
Unlike the ultimate determinations for the initial surface of the ulcer obtained in square millimeters.
Total ulcer area shall be measured by drawing software AUTOCAD LT 2014 , which defines the edges of the ulcer surface area in each of the two photographs , to take an average of the measure and get a value to be analyzed, that value is checked against the reference area of 1 square centimeter to increase measurement accuracy .
Measured: 15 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Mar 2014 (estimated)
- Study startMay 2014
- Primary completionOct 2014
- Study completionDec 2014
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Soft Tissue InfectionsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Triple blind
- Who is masked
- Participant, Care provider, Investigator
- Enrolment
- 24 participants (actual)
Sponsor and investigators
- Lead sponsor
- Universidad de Guanajuato
- Sponsor type
- University, hospital or other
- Collaborators
- National Council of Science and Technology, Mexico
- Responsible party
- Principal investigator, Alejandro E. Macias, Universidad de Guanajuato
- Investigators
- Hugo A Manriquez Perez, Physician, Principal investigator, Universidad de Guanajuato
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02097615
- Sponsor's protocol ID
- GTSSA02101-298
- Status last verified
- Dec 2014
- First submitted
- 24 Mar 2014
- Last updated
- 19 Aug 2016
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 19 Aug 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Clinical Trial of the Effectiveness of Chlorhexidine Gluconate 0.125 % Compared With Sterile Deionized Water in the Closure of Diabetic Foot Ulcer Syndrome.
- ClinicalTrials.gov ID
- NCT02097615
- Acronym / sponsor ID
- GTSSA02101-298
- Conditions
- Soft Tissue Infections
- Keywords
- soft, tissue, infections
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 24 participants (actual)
- Lead sponsor
- Universidad de GuanajuatoUniversity, hospital or other
- Collaborators
- National Council of Science and Technology, Mexico
- Study start
- May 2014
- Primary completion
- Oct 2014 (actual)
- Study completion
- Dec 2014 (actual)
- First posted
- 27 Mar 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
At present research has generated controversy regarding the utility of antiseptics in wound management for diabetic foot ulcers syndrome. However, these studies have been done in tissues and animal models. This study involves the best presently antiseptic for residual effect and low toxicity in an approach to eliminate microorganisms promoters formation of biofilm, contributing to the treatment for accelerated closure the diabetic foot ulcers syndrome .
So it is necessary to determine if irrigation ulcer diabetic foot syndrome with chlorhexidine 0.125 % aqueous solution determines the decrease of the surface to a greater extent than the standard treatment using irrigation with sterile deionized water .
Detailed description
The present study be made performed at the Hospital General Leon.
Population:
People with Diabetes Mellitus state of Guanajuato.
Universe:
People with diabetes mellitus and diabetic foot syndrome Guanajuato state . sample: Will be evaluated in patients with diabetes mellitus presenting loss of continuity of the skin of the lower limbs and coming to the clinic wound´s of the León General Hospital . This clinic provides services to patients in the state of Guanajuato with diabetic foot syndrome, including them within a multidisciplinary management program .
Calculation of Sample :
72 patients; more eight for lost estimates, 40 patients for each group are required to have a 80 % chance of detecting , with a significance level of 5%, an increase in the primary outcome measure of 5% in the control group and 6 % in group experimental .
Alpha: 5 % Power : 80 %
Inclusion Criteria:
Indistinct gender Patients over 18 years with Diabetes Mellitus and submit ulcer from diabetic foot syndrome not involving tendon , capsule or bone.
With proper state of vascular perfusion.
Exclusion Criteria :
Ulcers in patients with interdigital or difficult to measure the affected surface areas.
Patients not be located at follow-up or wish to stop participating in the study.
Methodology:
Will be invited to participate in the study patients with diabetes mellitus consecutive presented with ulcers plantar to IA or IB grade classification system ulcers , University of Texas, in the area of Clinical wound´s of the Hospital General Leon between Abril and November 2014.
After explaining the study information and check which is understandable , they provide the sheet to be signed informed consent.
Subsequently selected patients will be given a vascular ultrasound to measure the ankle brachial index and determine the absence of vascular compromise.
They carry out their medical history with emphasis on analyzing clinical data , including the characteristics of the ulcer (type of exudate , measured surface area affected , type of tissue involved in the ulcer to its depth ) and biochemical parameters .
Be weighed and measured at the first visit and not having biochemical data are requested to collect this information in subsequent follow-up visit .
They were then treated with the principles of the standard treatment, under the following criteria :
- Remove the ulcer exudate by spraying one of the two ingredients making mechanical drive for 5 minutes, or until completely negative to the visual evidence of exudate.
- Completely remove hyperkeratosis and devitalized tissue from the periphery of the ulcer with cutting material dissection with sterile dressing and drag , until visually eliminate the exudate.
- The treated area is dry and sore
- Two photographs at a distance of 20 cm perpendicular to the ulcer will be taken, covering a 1 square centimeter reference for measuring the area affected by diabetic foot ulcer syndrome.
- The solution so blinded to the ulcer and covered with sterile dressing will be applied for 24 hours .
- The patient will be instructed to continue treatment every 24 hours as follows :
- Sterile dressing will be removed and continuously irrigate for 5 seconds with the ingredient that was assigned .
- Undiscovered for 24 hours , until the next day irrigation dressing area will be placed . Also need to avoid contact with any surface over the affected area until the next assessment .
- Perform the same strategy for 24 hours , and on day 7 will go to the wound clinic to clinical evaluation.
- Every 7 days until complete 6 views, clinical evaluation are performed, irrigation with the selected ingredient and it will take 2 pictures at a distance of 20 cm perpendicular to the boil again , covering a reference of 1 square centimeter to measure the area affected by the diabetic foot ulcer syndrome.
- Every 7 days of initiation of therapy in the clinic consultation wounds measured and circulation and comment the following:
- Ulcer area in square millimeters .
- Coloring of the ulcer .
- Type of exudate ; turbid serous .
- Type of tissue involved in the ulcer to its depth. If any patients have increased intensity of the signs and symptoms of diabetic foot syndrome, classified as a major step on the scale of ulcers Classification System of the University of Texas, perform analysis and comprehensive treatment will be redefined according to the suggestions of ulcer classification system of the University of Texas.
Material cleaning the ulcer :
Ingredient 1: Preparation of spray application of chlorhexidine gluconate 0.125% .
Ingredient 2: Preparation of spray application of sterile deionized water .
Method of application of ingredients as described previously .
Method of randomization : is effected by assigning random numbers balanced computer, the code will be assigned to each of the ingredients which have identical presentations , they will balance to the sample size . The code will not be known by the patient, observer and analyst. Only be known by one of the advisors.
Statistical methods :
The description of the data, in the case of non-numerical variables will be performed by reporting proportions and confidence interval of 95 % (95 %) in the case of numerical variables, the description will be made based on averages and standard deviation or medians and Q1- Q3 range , depending on the result of the Kolmogorov-Smirnov test to evaluate the Gaussian distribution of the data.
Comparison of numerical variables were not performed by Chi square test . Comparison of the rates of reduction in the size of ulcers of diabetic foot syndrome for both treatments will be based on the t test for independent samples or by Kruskal- Wallis test , depending on data distribution .
In all cases be considered as the significance level alpha value <0.05 .
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Single group
- Masking
- Triple blind (participant, care provider, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| chlorhexidine gluconate | Experimental | Procedure: chlorhexidine gluconateapplication every 24 hours, six weeks |
| Other: deionized water | Other | Other: deionized waterapplication every 24 hours, six weeks |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Indistinct gender
- Patients over 18 years with Diabetes Mellitus and
- Submit ulcer from diabetic foot syndrome not involving tendon , capsule or bone.
- With proper state of vascular perfusion.
Key exclusion criteria (2 listed)
- Ulcers in patients with interdigital or difficult to measure the affected surface areas.
- Patients not be located at follow-up or wish to stop participating in the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| chlorhexidine gluconatechlorhexidine gluconate spray of 0.125% . Application in the area of the ulcer every 24 hours for six weeks | Procedure or surgery | chlorhexidine gluconate |
| deionized waterapplication every 24 hours six weeks | Other | Other: deionized water |
Primary outcome
Unlike the ultimate determinations for the initial surface of the ulcer obtained in square millimeters.
Time frame: 15 days
Total ulcer area shall be measured by drawing software AUTOCAD LT 2014 , which defines the edges of the ulcer surface area in each of the two photographs , to take an average of the measure and get a value to be analyzed, that value is checked against the reference area of 1 square centimeter to increase measurement accuracy .
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Aug 2016.
Related trials for Soft Tissue Infections
Recruiting
AYAHIV Role-based Responsibilities for Oncology-focused Workforce (ARROW)
Cervical Cancer, Kaposi Sarcoma
RecruitingObservational study
Natural History Study of Kaposi Sarcoma
Kaposi Sarcoma, HIV
Active, not recruitingPhase 2
Trial of Ixazomib for Kaposi Sarcoma
Kaposi Sarcoma, Skin
Active, not recruitingPhase 1
Pomalidomide in Combination With Liposomal Doxorubicin in People With Advanced or Refractory Kaposi Sarcoma
Kaposi Sarcoma
RecruitingPhase 1/2
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hugo A Manriquez Perez, Physician principal investigator
Universidad de Guanajuato
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing chlorhexidine gluconate and deionized water in people with Soft Tissue Infections, run by Universidad de Guanajuato at 1 site in Mexico.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 19 Aug 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Mexico. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Unlike the ultimate determinations for the initial surface of the ulcer obtained in square millimeters. (time frame: 15 days). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2016.